Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in <i>ApoE</i><sup>−/−</sup> Mice

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in <i>ApoE</i><sup>−/−</sup> Mice

Bacille-Calmette Guérin (BCG) modulates atherosclerosis development in experimental animals, but it remains unclear whether neonatal BCG vaccination is pro- or anti-atherogenic. Many animal models differ fundamentally from BCG administration to human infants in terms of age, vaccine preparation, dos...

Full description

Bibliographic Details
Main Authors: Siroon Bekkering, Krishan Singh, Hui Lu, Albert P. Limawan, Claudia A. Nold-Petry, Megan J. Wallace, Nigel Curtis, Salvatore Pepe, Michael Cheung, David P. Burgner, Timothy Moss
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biology
Subjects:
atherosclerosis
neonatal vaccination
BCG
inflammation
<i>ApoE</i><sup>−/−</sup>
Online Access:https://www.mdpi.com/2079-7737/11/10/1511

Internet

https://www.mdpi.com/2079-7737/11/10/1511

Similar Items